About
Jorge Bartolome is a pharmaceutical and biotechnology executive currently serving as Chief Executive Officer and Director of Rivus Pharmaceuticals. He previously served as CEO and Director of AreteiaTx/Areteia Therapeutics and earlier held senior commercial leadership roles at Janssen Canada and GlaxoSmithKline. His operating background centers on respiratory and cardiometabolic therapeutics, late-stage clinical development, commercialization, and company building in venture-backed biotech.
Areas of interest
biotechpharmaceuticalsrespiratory therapeuticsasthmaCOPDcardiometabolic diseaseMASHobesitylate-stage clinical developmentcommercialization